PDCD1 and neoplasm: In an experimental setting, Strauss et al. showed that myeloid-specific PD1 ablation in mice prevents the accumulation of granulocytic precursors and MDSC and was more effective than T-cell-specific PD1 ablation in reducing tumor growth by enhancing the antitumor T-cell response [10].